Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Leukemia

  Free Subscription


03.02.2025

2 Acta Haematol
1 Am J Clin Oncol
4 Am J Hematol
1 Biochem Pharmacol
3 Blood
1 Bone Marrow Transplant
1 Cancer
1 Cancer Lett
1 Eur J Haematol
2 J Biol Chem
2 Leukemia
1 Oncol Rep
1 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. OANUNU U, Gross Even Zohar N, Aumann S, Vainstein V, et al
    Prognostic Factors, FLT-3 Mutations, and Treatment Outcomes with pediatric inspired protocols in adolescent and young adults (AYA) and adult patients with Acute Lymphoblastic Leukemia.
    Acta Haematol. 2025 Jan 30:1-24. doi: 10.1159/000543861.
    PubMed         Abstract available

  2. CHO HJ, Baek DW, Kim J, Jang YE, et al
    Real-World Experience in the Management of Chronic Myeloid Leukemia Patients Focused on Tyrosine Kinase Inhibitors Intolerance and Health-Related Quality of Life.
    Acta Haematol. 2025 Jan 10:1-14. doi: 10.1159/000542562.
    PubMed         Abstract available


    Am J Clin Oncol

  3. AHMED S, Ahmad E, Ashraf H, Ashfaq H, et al
    Trends and Disparities in Acute Lymphoblastic Leukemia-Related Mortality in the United States from 1999 to 2020: Insights From the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research Database.
    Am J Clin Oncol. 2025 Jan 31. doi: 10.1097/COC.0000000000001162.
    PubMed         Abstract available


    Am J Hematol

  4. MAYER J, Cicatkova P, Kovacova L, Jarosova M, et al
    Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia.
    Am J Hematol. 2025 Jan 28. doi: 10.1002/ajh.27608.
    PubMed         Abstract available

  5. HALLEK M
    Chronic Lymphocytic Leukemia: 2025 Update on the Epidemiology, Pathogenesis, Diagnosis, and Therapy.
    Am J Hematol. 2025 Jan 28. doi: 10.1002/ajh.27546.
    PubMed         Abstract available

  6. WEI Q, Hu S, Loghavi S, Toruner GA, et al
    Chromoanagenesis Is Frequently Associated With Highly Complex Karyotypes, Extensive Clonal Heterogeneity, and Treatment Refractoriness in Acute Myeloid Leukemia.
    Am J Hematol. 2025 Jan 27. doi: 10.1002/ajh.27575.
    PubMed         Abstract available

  7. ENGELMANN R, Flores-Montero J, Schilperoord-Vermeulen J, Ritgen M, et al
    Novel Flow Cytometric Antibody Panel and Dedicated Analysis Algorithm for Automated Fully Standardized Minimal Residual Disease Detection in Chronic Lymphocytic Leukemia.
    Am J Hematol. 2025 Jan 25. doi: 10.1002/ajh.27604.
    PubMed        


    Biochem Pharmacol

  8. HAN YU P, Yan Zhang Z, Yuan Kang Y, Huang P, et al
    Acute myeloid leukemia with t(8;21) translocation: Molecular pathogenesis, potential therapeutics and future directions.
    Biochem Pharmacol. 2025;233:116774.
    PubMed         Abstract available


    Blood

  9. LYAPICHEV KA, Behdad A
    c-MYC stain as a potential minimal residual disease marker for acute myeloid leukemia with NPM1 mutation.
    Blood. 2025;145:547.
    PubMed        

  10. POHLY MF, Putzker K, Scheinost S, Ben Taarit L, et al
    IAP dependency of T-cell prolymphocytic leukemia identified by high-throughput drug screening.
    Blood. 2025 Jan 27:blood.2024027171. doi: 10.1182/blood.2024027171.
    PubMed         Abstract available

  11. ABEDIN SM, Uy GL, Michaelis LC
    The Fit Older Adult with Acute Myeloid Leukemia: Clinical Challenges to Providing Evidence-Based Frontline Treatment.
    Blood. 2025 Jan 24:blood.2024026004. doi: 10.1182/blood.2024026004.
    PubMed         Abstract available


    Bone Marrow Transplant

  12. NEUPANE B, Ventura K, Parr K, Lee JR, et al
    Dynamics of neoantigen-specific T-cells in post-transplant relapse: do leukemia neoantigens elicit immune responses in transplant recipients?
    Bone Marrow Transplant. 2025 Jan 29. doi: 10.1038/s41409-025-02515.
    PubMed        


    Cancer

  13. ESKAZAN AE
    Patient-reported outcomes in Chinese patients with chronic myeloid leukemia receiving olverembatinib: Quality of life matters!
    Cancer. 2025;131:e35737.
    PubMed        


    Cancer Lett

  14. WEISS S, Zdarsky B, Witalisz-Siepracka A, Edtmayer S, et al
    Atovaquone and selinexor as a novel combination treatment option in acute myeloid leukemia.
    Cancer Lett. 2025;613:217501.
    PubMed         Abstract available


    Eur J Haematol

  15. HYPPOLITO JE, Arcuri LJ, Vicente A, Farnese V, et al
    Central Nervous System Involvement in Chronic Lymphocytic Leukemia: A Case-Series.
    Eur J Haematol. 2025 Jan 31. doi: 10.1111/ejh.14389.
    PubMed        


    J Biol Chem

  16. HARDWICK J, Rodriguez-Hernaez J, Gambi G, Venters BJ, et al
    The common murine retroviral integration site activating Hhex marks a distal regulatory enhancer co-opted in human Early T-cell precursor leukemia.
    J Biol Chem. 2025 Jan 27:108233. doi: 10.1016/j.jbc.2025.108233.
    PubMed         Abstract available

  17. SELZER AM, Gerlach G, Gonzalez-Areizaga G, Wales TE, et al
    An SH3-binding allosteric modulator stabilizes the global conformation of the AML-associated Src-family kinase, Hck.
    J Biol Chem. 2025;301:108088.
    PubMed         Abstract available


    Leukemia

  18. ABLE M, Kasper MA, Vick B, Schwach J, et al
    Effective eradication of acute myeloid leukemia stem cells with FLT3-directed antibody-drug conjugates.
    Leukemia. 2025 Jan 27. doi: 10.1038/s41375-024-02510.
    PubMed         Abstract available

  19. LIU J, Kharazmi E, Liang Q, Chen Y, et al
    Maternal weight during pregnancy and risk of childhood acute lymphoblastic leukemia in offspring.
    Leukemia. 2025 Jan 26. doi: 10.1038/s41375-025-02517.
    PubMed         Abstract available


    Oncol Rep

  20. LIU YH, Zhu M, Lei PP, Pan XY, et al
    [Corrigendum] ND?09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR?ABL signaling.
    Oncol Rep. 2025;53:37.
    PubMed         Abstract available


    PLoS One

  21. HU Z, Ge A, Wang X, Ou C, et al
    Evaluation of the practical application of the category-imbalanced myeloid cell classification model.
    PLoS One. 2025;20:e0313277.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  22. JIN GB, Rong SQ, Yin DR, Deng ZH, et al
    Neomorphic leukemia-derived mutations in the TET2 enzyme induce genome instability via a substrate shift from 5-methylcytosine to thymine.
    Proc Natl Acad Sci U S A. 2025;122:e2418318122.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.